Madhi SA, Kwatra G, Richardson SI, Koen AL, et al. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial. Lancet Infect Dis 2022 Oct 20. pii: S1473-3099(22)00596.
PMID: 36273491